Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.

Lin Ru KoongWai Kitt CheeZhi Hong TohXin Le NgRupesh V AgrawalSu Ling Ho

Published in: Ocular immunology and inflammation (2021)

A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.

Keyphrases

high dose
coronavirus disease
sars cov
low dose
stem cell transplantation
case report
high resolution
binding protein
artificial intelligence
respiratory syndrome coronavirus
drug induced
aortic dissection
acute respiratory distress syndrome
photodynamic therapy
optical coherence tomography
deep learning